切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2020, Vol. 09 ›› Issue (06) : 515 -518. doi: 10.3877/cma.j.issn.2095-3232.2020.06.004

所属专题: 文献

专家论坛

合并肥胖肝移植患者减重手术策略
李乐1, 曲伟2, 张宇红2, 肖飞2, 朱志军2,()   
  1. 1. 100045 北京,首都医科大学附属北京友谊医院肝脏移植中心;024000 内蒙古自治区赤峰市医院肝胆外科
    2. 100045 北京,首都医科大学附属北京友谊医院肝脏移植中心
  • 收稿日期:2020-09-06 出版日期:2020-12-10
  • 通信作者: 朱志军

Bariatric surgery strategy for liver transplant patients complicated with obesity

Le Li1, Wei Qu2, Yuhong Zhang2   

  • Received:2020-09-06 Published:2020-12-10
引用本文:

李乐, 曲伟, 张宇红, 肖飞, 朱志军. 合并肥胖肝移植患者减重手术策略[J]. 中华肝脏外科手术学电子杂志, 2020, 09(06): 515-518.

Le Li, Wei Qu, Yuhong Zhang. Bariatric surgery strategy for liver transplant patients complicated with obesity[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2020, 09(06): 515-518.

[1]
Ogden CL, Carroll MD, Kit BK, et al. Prevalence of obesity among adults: United States, 2011-2012[J]. NCHS Data Brief, 2013(131):1-8.
[2]
Ward ZJ, Long MW, Resch SC, et al. Redrawing the US obesity landscape: bias-corrected estimates of state-specific adult obesity prevalence[J]. PLoS One, 2016, 11(3): e0150735.
[3]
Moss BG, Yeaton WH. Young children's weight trajectories and associated riskfactors: results from the Early Childhood Longitudinal Study-Birth Cohort[J]. Am J Health Promot, 2011, 25(3):190-198.
[4]
Zaydfudim V, Feurer ID, Moore DE, et al. The negative effect of pretransplant overweight and obesity on the rate of improvement in physical quality of life after liver transplantation[J]. Surgery, 2009, 146(2):174-180.
[5]
Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States[J]. Hepatology, 2002, 35(1):105-109.
[6]
Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States[J]. Gastroenterology, 2011, 141(4):1249-1253.
[7]
Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States[J]. Gastroenterology, 2015, 148(3):547-555.
[8]
Liou I, Kowdley KV. Natural history of nonalcoholic steatohepatitis[J]. J Clin Gastroenterol, 2006, 40 Suppl 1:S11-16.
[9]
Patil DT, Yerian LM. Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation[J]. Liver Transpl, 2012, 18(10): 1147-1153.
[10]
Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation[J]. Am J Transplant, 2004, 4(5):686-693.
[11]
Saab S, Cho D, Lassman RC, et al. Recurrent non-alcoholic steatohepatitis in a living related liver transplant recipient[J].J Hepatol, 2005, 42(1):148-149.
[12]
Lim LG, Cheng CL, Wee A, et al. Prevalence and clinical associations of posttransplant fatty liver disease[J]. Liver Transpl, 2007, 27(1):76-80.
[13]
Laish I, Braun M, Mor E, et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events[J]. Liver Transpl, 2011, 17(1):15-22.
[14]
McAlister VC, Haddad E, Renouf E, et al. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis[J]. Am J Transplant, 2006, 6(7):1578-1585.
[15]
Dumortier J, Giostra E, Belbouab S, et al. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil"[J]. Am J Gastroenterol, 2010, 105(3):613-620.
[16]
Perkins JD. Saying "Yes" to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation[J]. Liver Transpl, 2006, 12(6):1012-1013.
[17]
Ayloo S, Armstrong J, Hurton S, et al. Obesity and liver transplantation[J]. World J Transplant, 2015, 5(3):95-101.
[18]
中华医学会内分泌学分会肥胖学组.中国成人肥胖症防治专家共识[J].中华内分泌代谢杂志,2011, 27(9):711-717.
[19]
Lin MY, Tavakol MM, Sarin A, et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates[J]. Surg Obes Relat Dis, 2013, 9(5):653-658.
[20]
Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation[J]. Surg Obes Relat Dis, 2008, 4(2):159-164.
[21]
Heimbach JK, Watt KD, Poterucha JJ, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease[J]. Am J Transplant, 2013, 13(2):363-368.
[22]
Zamora-Valdes D, Watt KD, Kellogg TA, et al. Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy[J]. Hepatology, 2018, 68(2):485-495.
[23]
Butte JM, Devaud N, Jarufe NP, et al. Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation[J]. Obes Surg, 2007, 17(11):1517-1519.
[24]
Suraweera D, Dutson E, Saab S. Liver transplantation and bariatric surgery: best approach[J]. Clin Liver Dis, 2017, 21(2):215-230.
[25]
Lin MY, Tavakol MM, Sarin A, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation[J]. Surg Endosc, 2013, 27(1):81-85.
[26]
Osseis M, Lazzati A, Salloum C, et al. Sleeve gastrectomy after liver transplantation: feasibility and outcomes[J]. Obes Surg, 2018, 28(1): 242-248.
[27]
Toolabi K, Golzarand M, Farid R. Laparoscopic adjustable gastric banding: efficacy and consequences over a 13-year period[J]. Am J Surg, 2016, 212(1):62-68.
[28]
Vu L, Switzer NJ, De Gara C, et al. Surgical interventions for obesity and metabolic disease[J]. Best Pract Res Clin Endocrinol Metab, 2013, 27(2):239-246.
[29]
Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity[J]. Cochrane Database Syst Rev, 2009(2):CD003641.
[30]
Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study[J]. Ann Surg, 2008, 247(3):401-407.
[31]
Moshiri M, Osman S, Robinson TJ, et al. Evolution of bariatric surgery:a historical perspective[J]. AJR Am J Roentgenol, 2013, 201(1):W40-48.
[32]
Tavakol MM, Amirkiai S, Amin R, et al. Laparoscopic sleeve gastrectomy (LSG) is safe, well tolerated and improves candidacy in morbidly obese patients awaiting liver transplantation[J]. Transplantation, 2012, 94 Suppl:226.
[33]
Campsen J, Zimmerman M, Shoen J, et al. Adiustable gastric banding in a morbidly obese patient during liver transplantation[J]. Obes Surg, 2008, 18(12):1625-1627.
[34]
Guerrero Pérez F, Pia Marengo A, Fabregat J, et al. Combined sleeve gastrectomy and orthotopic liver transplantation in patient with type 2 obesity and advanced liver disease[J]. Endocrinol Diabates Nutr, 2017, 64(5):282-284.
[35]
Kumar S, Khandelwal N, Kumar A, et al. Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-first report from India[J]. Indian J Gastroenterol, 2017, 36(3):243-247.
[36]
Nesher E, Mor E, Shlomai A, et al. Simultaneous liver transplantation and sleeve gastrectomy: prohibitive combination or a necessity?[J]. Obes Surg, 2017, 27(5):1387-1390.
[37]
Tariciotti L, D'Ugo S, Manzia TM, et al. Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: first European case-report[J]. Int J Surg Case Rep, 2016(28):38-41.
[38]
Elli EF, Masrur MA, Giulianotti PC. Robotic sleeve gastrectomy after liver transplantation[J]. Surg Obes Relat Dis, 2013, 9(1):e20-22.
[39]
Pajecki D, Cesconetto DM, Macacari R, et al. Bariatric surgery (sleeve gastrectomy) after liver transplantation: case report[J]. Arq Bras Cir Dig, 2014, 27 Suppl 1:81-83.
[40]
Al-Nowaylati AR, Al-Haddad BJ, Dorman RB, et al. Gastric bypass after liver transplantation[J]. Liver Transpl, 2013, 19(12):1324-1329.
[41]
Lainas P, Dupond-Athenor A, Tranchart H, et al. Safety and feasibility of single-port sleeve gastrectomy following liver transplantation[J]. Obes Surg, 2018, 28(3):874-876.
[42]
Yemini R, Nesher E, Winkler J, et al. Bariatric surgery in solid organ transplant patients: long-term follow-up results of outcome, safety, and effect on immunosuppression[J]. Am J Transplant, 2018, 18(11):2772-2780.
[43]
Duchini A, Brunson ME. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity[J]. Transplantation, 2001, 72(1):156-159.
[1] . 肝移植治疗终末期肝病[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 1-.
[2] 李坤河, 寇萌佳, 邝立挺. 肝移植术后二次气管插管的危险因素及预测模型的建立[J]. 中华普通外科学文献(电子版), 2023, 17(05): 366-371.
[3] 纪凯伦, 郝少龙, 孙海涛, 韩威. 减重术后胆囊结石形成机制的新进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 100-103.
[4] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 上海医药行业协会. 中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(05): 257-272.
[5] 陆闻青, 陈昕怡, 任雪飞. 遗传代谢病儿童肝移植受者术后生活质量调查研究[J]. 中华移植杂志(电子版), 2023, 17(05): 287-292.
[6] 范铁艳, 李君, 陈虹. 肝移植术后新发戊型病毒性肝炎的诊治经验[J]. 中华移植杂志(电子版), 2023, 17(05): 293-296.
[7] 陈朔, 陈峰, 程飞, 项捷. 糖原累积病Ⅰ型并发胰腺炎肝移植术后胰腺梗死一例[J]. 中华移植杂志(电子版), 2023, 17(05): 300-302.
[8] 汤鹏昊, 张武. 肠道微生态与肝移植围手术期并发症相关研究进展[J]. 中华移植杂志(电子版), 2023, 17(05): 303-307.
[9] 祝丽娜, 杨子祯, 张迪, 张勇, 蔡金贞, 王建红. 超声造影在肝移植术后肝动脉并发症中的应用价值[J]. 中华移植杂志(电子版), 2023, 17(04): 240-245.
[10] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[11] 廖梅, 张红君, 金洁玚, 吕艳, 任杰. 床旁超声造影对肝移植术后早期肝动脉血栓的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 630-634.
[12] 李秉林, 吕少诚, 潘飞, 姜涛, 樊华, 寇建涛, 贺强, 郎韧. 供肝灌注液病原菌与肝移植术后早期感染的相关性分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 656-660.
[13] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[14] 王孟龙. 肿瘤生物学特征在肝癌肝移植治疗中的意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 490-494.
[15] 王晓东, 汪恺, 葛昭, 丁忠祥, 徐骁. 计算机视觉技术在肝癌肝移植疗效提升中的研究进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 361-366.
阅读次数
全文


摘要